Biotech

All Articles

Lykos will definitely talk to FDA to reexamine its choice observing being rejected of MDMA treatment for trauma

.Adhering to a bad presenting for Lykos Rehabs' MDMA applicant for trauma at a latest FDA consultato...

AN 2 fifty percents census, quits phase 3 trial after information disappoint

.AN2 Rehabs is reassessing its own company in action to dull midphase information, vowing to lay off...

Merck pays for $700M for bispecific, snooping autoimmune position and also possibility to test Amgen in cancer cells

.Merck &amp Co. is actually paying for $700 thousand beforehand to challenge Amgen in a blood cancer...

Gilead spends J&ampJ $320M to leave licensing deal for seladelpar

.Along With Gilead Sciences about to an FDA selection for its liver illness medicine seladelpar, the...

' All hands on deck' at Lilly as peers target excessive weight market

.CEO David Ricks can see the providers establishing outdoors tents at basecamp behind Eli Lilly in a...

Entero laying off team, abandoning workplace and stopping briefly R&ampD

.Mattress Liquidators has actually transformed Entero Therapies white as a sheet. The collector orde...

Exelixis goes down ADC after choosing it's no match for Tivdak

.Exelixis is losing hope on its tissue variable (TF)- targeting antibody-drug conjugate after conclu...

Relay loses interest in SHP2 prevention after Genentech leaves behind

.3 full weeks after Roche's Genentech unit ignored an SHP2 prevention pact, Relay Therapy has actual...

Stoke's Dravet syndrome med launched of predisposed medical grip

.Stoke Rehabs' Dravet disorder medicine has been actually without a partial hold, getting rid of the...

Fierce Biotech's Gabrielle Masson offers Brutal 15 at NYSE

.Fierce Biotech Partner Publisher Gabrielle Masson provided the 2024 lesson of Brutal 15 victors on ...